Fri, January 8, 2021

Arun Viswanathan Upgraded (CC) to Buy and Increased Target to $35 on, Jan 8th, 2021

Arun Viswanathan of RBC Capital, Upgraded "The Chemours Company" (CC) to Buy and Increased Target from $27 to $35 on, Jan 8th, 2021.

Arun has made no other calls on CC in the last 4 months.



There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 2 agree with Arun's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $28 on, Monday, December 14th, 2020
  • Duffy Fischer of "Barclays" Downgraded from Buy to Hold and Increased Target to $28 on, Friday, December 4th, 2020


This is the rating of the analyst that currently disagrees with Arun


  • John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $28 on, Thursday, November 5th, 2020